Page 174 - IJB-8-2
P. 174

Nephrotoxicity Testing with Bioprinted Renal Spheroids
           after 3 days of treatment with different concentrations of   cell culture medium containing a dilution of cisplatin
           cisplatin. The composition of this dataset is described in the   (c Cisplatin  = 100  µM).  The treatment was conducted at
           Table S1. The network architecture and hyperparameters   37°C  for 24 h. Then, the cisplatin dilution was replaced
           were chosen by automatic hyperparameter optimization.   by fresh medium.  At this time point, we started the
           The selected architecture was a VGG11 optimized with   readout.  During the  subsequent incubation period, the
           ADAM for 90 epochs. The full list of hyperparameters   supernatant was sampled at different time points (0, 12,
           is  provided  in  the  Supplementary  File. The  concept  of   24, 36, 48, and 72 h post treatment), and the release of
           automated  treatment  effect  readout  was  adapted  from   LDH was quantified. The measured LDH release curves
           previous studies [11,12] .                          for the 2 sample types are shown in Figure 1D and E.
                                                               For 2D monolayer cultures, no significant LDH release
           3. Results and discussion                           was  detected  within  the  first  24  h  (Figure  1D). After

           3.1. Required 3D cell  count for toxicity           36  h,  the  LDH  release  accounted  for  60  ±  20%  and
           quantification                                      increased to 96 ± 20% after 48 h, relative to the Lysed
                                                               Ctrl. At 72 h post-treatment, the released LDH decreased
           First, the required total  cell count per 3D sample was   to 42 ± 23%. The decrease in measured LDH could be
           defined, which enabled the quantification of toxicity with   related to the degradation of the enzyme in the culture
           a chemical  LDH assay readout.  Therefore,  cell  cluster   supernatant. For the untreated control group (Neg. Ctrl),
           arrays were fabricated, ranging from 1 to 400 spheroids   the release of LDH continuously increased over time,
           (Figure 1A). The cell clusters self-assembled to spheroids   reaching a maximum of 10 ± 7% at 72 h. This could be
           of uniform size within 4 days of incubation . Then, the   explained  by  the  fact  that the  2D  monolayer  cultures
                                                [8]
           spheroids were lysed (Lysed Ctrl),  and the amount  of   were fully confluent. At this point, the cells in culture
           released LDH was compared to the Neg. Ctrl. (Figure 1B).   need to adapt to the limited growth area and nutrient
           The Lysed Ctrl samples showed an increasing amount   deficiency, which could cause unspecific cell lysis and
           of LDH in  the supernatant  in relation  to  an  increasing   LDH release. The 3D spheroid arrays showed a distinct
           number of spheroids per array, as expected. In contrast,   behavior compared to the 2D monolayers (Figure 1E).
           the Neg. Ctrl samples showed a constant absorbance,   The  first  increase  in  LDH  release  occurred  24  h  post-
           independent of the cell count. The positive to negative   treatment, reaching 60 ± 32% of the Lysed Ctrl. After
           signal ratio (SP/N = Lysed Ctrl/Neg. Ctrl) was calculated   48 h, the maximum was reached at 96 ± 7%. Afterward,
           to determine  the minimum  spheroid count required   the value declined to 79 ± 27% (72 h). Again, this decline
           to  distinguish the  Lysed Ctrl. from  the  Neg. Ctrl.  The   could be explained by an impairment of the LDH activity
           desired value of SP/N ≥3 was achieved for  arrays with   due to the progressive incubation period. The untreated
           at least 100 spheroids. For these, an OD 450_100  = 0.8 ± 0.6   control shared a similar behavior with the 2D monolayers,
           was  measured,  showing  a  high  coefficient  of  variation   with a slight and static linear increase of released LDH
           (75%). A number of 225 spheroids showed an absorbance   over  time,  reaching  a  maximum  of  23  ±  1%  at  72  h.
           of OD 450_225  = 1.3 ± 0.4. In addition, the lowest coefficient   This indicates again that within 3D spheroid cultures,
           of variation was found for this format (30%). In addition,   unspecific cell lysis occurred, which was not related to a
           the value was in the range of the LDH Ctrl, which was   toxic treatment. This finding is in good accordance with
           measured  to OD 450_LDH Ctrl  = 1.6 ± 0.3, corresponding   the previously published data .  Taken together, from
                                                                                         [15]
           to 83 ± 25%. The largest array format (400 spheroids)   the experiments, the optimal time-point for the LDH-
           showed an absorbance of 114 ± 47% relative to the LDH   assay based readout was found to be at  t treatment  = 48 h.

           Ctrl, however, with an increased coefficient of variation.   The dynamic observation of LDH release after cisplatin
           Based  on  these  findings,  spheroid  arrays  consisting  of   treatment  indicated  significant  differences  between
           225 spheroids, or 34×10   cells, were selected for the   2D and 3D cell models. The faster onset of toxicity in
                                 6
           quantification of toxicity using an LDH assay.      3D models could be related to a more efficient uptake
                                                               of the toxin. In the case of cisplatin, the uptake occurs
           3.2. 3D response time to toxic treatment            through transport proteins located on the basal side of the

           Next, a suitable time-point for the toxicity readout was   cells. This side is facing toward the cisplatin containing
           determined. A  schematic timeline of the experimental   culture medium in the case of hydrogel embedded 3D
           procedure is  shown in  Figure  1C.  All samples  were   spheroids, while in 2D monolayers it is in contact to the
           prepared by bioprinting 4 days before a treatment with   solid culture vessel surface.
           cisplatin, a common nephrotoxic substance . Two types   3.3. Dose-response curves
                                               [14]
           of samples were prepared, either classical monolayers
           (2D) or bioprinted arrays of 225 spheroids (3D Samples).   Next,  dose-dependent  treatment  effects  were  quantified
           On day 4 of incubation, the medium was replaced by a   to derive dose-response curves for different cell culture

           166                         International Journal of Bioprinting (2022)–Volume 8, Issue 2
   169   170   171   172   173   174   175   176   177   178   179